BioInvent International AB banner

Intrinsic Value

The intrinsic value of BioInvent International AB (BOVNF) under the Base Case is USD per share. Compared with the current market price of 0.2798 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

BOVNF Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when BOVNF is below its intrinsic value
Today Hidden ·
BOVNF Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to BOVNF

Fundamental Analysis

What BioInvent International AB Does

Biotechnology Health Care

BioInvent International AB is a Swedish biotech company that discovers and develops antibody-based medicines, mainly for cancer. It does not sell consumer products; instead, it creates drug candidates and research tools that are meant to be tested in clinical studies and then licensed or partnered with larger drugmakers. Its work centers on finding antibodies that can help the immune system attack tumors or block signals that cancer cells use to grow.

Headquarters
Sweden SE
Employees
112
IPO date
Jun 12, 2001
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue BOVNF Research

Decided on BioInvent International? Get an email when BOVNF reaches the price you’d buy at. Free with an account.

Other BioInvent International listings

What is the Intrinsic Value of one BOVNF stock?

The intrinsic value for BioInvent International AB (BOVNF) under the Base Case is USD.

Is BOVNF stock undervalued or overvalued?

Compared with the current market price of 0.2798 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top